Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3187

Actual shortage: 258 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2918 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-METFORMIN 850MG TABLET Resolved 2020-10-01 2020-10-22 125455
TEVA-METFORMIN 850MG TABLET Resolved 2023-01-19 2023-04-28 181594
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-05-16 2024-09-19 228143
ACT NABILONE 1MG CAPSULE Resolved 2019-10-17 2020-03-12 96733
ACT NABILONE 1MG CAPSULE Resolved 2019-12-19 2020-03-12 101730
ACT NABILONE 0.5MG CAPSULE Resolved 2019-12-19 2020-03-12 101740
ACT NABILONE 0.5MG CAPSULE Resolved 2020-04-16 2021-09-23 112394
ACT NABILONE 0.5MG CAPSULE Resolved 2020-07-16 2020-08-07 120459
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
TEVA-OLMESARTAN 40MG TABLET Resolved 2018-10-22 2020-06-11 65340

Showing 181 to 200 of 3187

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65298
ACT VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65305
ACT ZOPICLONE 5MG TABLET Discontinued 2018-10-22 2018-10-22 65191
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65213
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65218
AERMONY RESPICLICK 55MCG POWDER (METERED DOSE) Discontinued 2024-11-05 2024-11-05 242101
AERMONY RESPICLICK 113MCG POWDER (METERED DOSE) Discontinued 2025-05-28 2025-05-28 258571
AERMONY RESPICLICK 232MCG POWDER (METERED DOSE) Discontinued 2025-09-02 2025-09-02 266350
ALERTEC 100MG TABLET Discontinued 2025-05-28 2025-05-28 258777
ALLERNIX 25MG TABLET Discontinued 2025-05-28 2025-05-28 258595
ALLERNIX EXTRA STRENGTH 50MG TABLET Discontinued 2025-05-28 2025-05-28 258562
AZILECT 1MG TABLET Reversed 2025-05-28 2025-06-04 258705
AZILECT 1MG TABLET Reversed 2025-05-28 2025-06-04 258771
BALMINIL DM (3MG/ML SUCROSE FREE) 15MG SYRUP Discontinued 2025-05-28 2025-05-28 258741
BALMINIL EXPECTORANT (SUCROSE FREE) 100MG SYRUP Discontinued 2025-05-28 2025-05-28 258750
BORTEZOMIB FOR INJECTION 3.5MG POWDER FOR SOLUTION Discontinued 2025-04-29 2025-04-29 256094
CALMYLIN ACE 10MG 7.5MG 100MG SYRUP Discontinued 2024-06-28 2024-06-29 231574
CEFAZOLIN FOR INJECTION 0.5G POWDER FOR SOLUTION Discontinued 2019-08-08 2019-08-08 91175
CEFAZOLIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2023-11-27 2023-11-27 211558
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2020-05-14 2020-05-14 115088

Showing 61 to 80 of 435